The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Convergent action on AMR identified as an important area of intervention
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
Subscribe To Our Newsletter & Stay Updated